Final programme - eshre 2013

More documents

Recommendations

Info

Overview Wednesday, 10 July 201308.30 - 09.30Session 52: Future infertility management−−When will infertility be explained? - Robert W. Rebar (U.S.A.)−−The future of randomized clinical trials - P.M.M. Bossuyt (The Netherlands)Auditorium08.30 - 09.30Session 53: Are human embryonic stem cells ready for regenerativemedicine?−−hESC and iPSC as models for human development and disease -Rita Vassena (Spain)−−Cell therapy with pluripotent stem cells (hESC and iPS) -Benjamin Reubinoff (Israel)Capital Hall A08.30 - 09.30Session 54: New findings in reproductive oncology−−Ovarian cancer and the incessant menstruation hypothesis -Edgardo Somigliana (Italy)−−Obesity and breast cancer: role of inflammation and dysregulatedmetabolism? - Evan Simpson (Australia)Capital Suite A08.30 - 09.30Session 55: ASRM/Society of Reproductive Biologists and TechnologistsExchange Symposium: Optimizing the culture and selection of humanembryo in 2013−−Current status of non-invasive approaches for embryo assessmentand selection - Catherine Racowsky (U.S.A.)−−Evaluating media systems and day of transfer for human embryos:What are optimal? - Michael John Tucker (U.S.A.)Capital Hall B08.30 - 09.30Session 56: From experimental to established: ESHRE guidelines andposition papers−−The 2013 ESHRE guideline on the management of women withendometriosis. - Gerard A.J. Dunselman (The Netherlands)−−On the notion of the experimental - Veerle Provoost (Belgium)S8 - B09.30 - 10.00Coffee breakExhibit hall10.00 - 11.15Besins Healthcare Company Symposium - “Luteal phase support:Building on firm foundations”Auditorium10.00 - 11.45Session 57: Time lapse: the real revolution for embryo assessment?Capital Hall A10.00 - 11.30Session 58: Basics of reproductive endocrinologySession 59: EndometriumSession 60: Perinatal outcome after ARTSession 61: Effects of interventions on embryo qualityCapital Suite ACapital Hall BS8 - AS8 - B112
12.00 - 13.00Session 62: Quality management and regulation in the ART labAuditorium−−From quality control to total quality management in the IVF lab -Kelly Tilleman (Belgium)−−The European Tissue Directive: a curse or a blessing? -Basil C. Tarlatzis (Greece)12.00 - 13.00Session 63: New ART interventions may, under certain circumstances,Capital Hall Abe introduced without a clinical trial? (Debate)−−For - Simon Fishel (United Kingdom)−−Against - Sigrid Sterckx (Belgium)12.00 - 13.00Session 64: Endometriosis-associated pain−−Endometrium, nerves and endometriosis - Ian S. Fraser (Australia)−−Central nervous system (CNS) mechanisms of pain in endometriosis -Karen Berkley (U.S.A.)Capital Suite ACOMMITTEES12.00 - 13.00Session 65: Paramedical invited session - Nursing (Debate):S8 - BPatients have the right for an anonymous donor−−Pro - Lone Schmidt (Denmark)−−Con - Claes Gottlieb (Sweden)13.00 - 14.00Lunch break and Poster viewing and discussion at the Speakers' CornerExhibit hallin the poster area.14.00 - 15.15Session 66: Embryo quality: does it predict pregnancy?AuditoriumSession 67: Scientific challenges in early pregnancy achievementCapital Hall ASession 68: The impact of genetics in andrologyCapital Suite ASession 69: Clinical endocrinologyCapital Hall BSession 70: Challenges in cryopreservationS8 - ASession 71: SurgeryS8 - B15.30 - 16.30Session 72: Awards and closing ceremonyCapital Suite AWEDNESDAYProgramme book113
Page 1:
London - United Kingdom 7 to 10 Jul
Page 9 and 10:
Contents007 Welcome009 Committees01
Page 11:
Session 48:Session 49:Session 50:Se
Page 18 and 19:
Committee of National Representativ
Page 23 and 24:
GENERAL INFORMATION−−Political
Page 25 and 26:
Greater London is served by 12 Tube
Page 27:
GENERAL INFORMATIONProgramme book17
Page 32 and 33:
Monday 8 July 201308.00 - 17.30 IFF
Page 35 and 36:
Agenda of the 2013 Annual GeneralAs
Page 37:
AGENDAProgramme book25
Page 41:
SOCIAL PROGRAMMEOpening Ceremony an
Page 44 and 45:
COURSE 1Sunday, 7 July−−Room Ca
Page 46 and 47:
Chairman: Willem Ombelet (Belgium)1
Page 48 and 49:
New thoughtsChairman: Mariette Godd
Page 50 and 51:
Page 52 and 53:
COURSE 7Sunday, 7 July−−−−
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
COURSE 11Sunday, 7 July−−Room C
Page 60 and 61:
course 12Sunday, 7 July−−Room C
Page 62 and 63:
Course 13Sunday, 7 July−−Room C
Page 64 and 65:
course 15Sunday, 7 JulyRoom Capital
Page 66 and 67:
Overview MONDAY, 8 July 201308.00 -
Page 68 and 69:
Monday 8 July 2013Invited session08
Page 70 and 71:
Monday 8 July 2013Selected oral com
Page 72 and 73:
Page 74 and 75:
Page 76 and 77: Monday 8 July 2013Invited session11
Page 80 and 81: Monday 8 July 2013Company symposium
Page 84 and 85: Monday 8 July 2013Selected oral com
Page 92 and 93: Overview TUESDAY, 9 July 201308.30
Page 94 and 95: Tuesday 9 July 2013Invited session0
Page 98 and 99: Tuesday 9 July 2013Selected oral co
Page 104 and 105: Tuesday 9 July 2013Company symposiu
Page 108 and 109: Tuesday 9 July 2013Company symposiu
Page 128 and 129: Wednesday 10 July 2013Invited sessi
Page 134 and 135: Wednesday 10 July 2013Selected oral
Page 150 and 151: 136
Page 152 and 153: Tuesday, 10 July13.00 P-050 Health
Page 154 and 155: POSTERSAndrologyP-001 Magnetic Acti
Page 156 and 157: P-028 Female age and number of retr
Page 158 and 159: P-054 Genomic rearrangements and CN
Page 160 and 161: P-079 A modified cryotop vitrificat
Page 162 and 163: P-109 Effect of early blastomere mu
Page 164 and 165: P-138 Cyclin E1 as a new ICM marker
Page 166 and 167: P-167 Single medium culture in a ti
Page 168 and 169: P-196 Early cleaving mouse embryos
Page 170 and 171: P-225 Luteal phase support has a be
Page 172 and 173: P-252 Correlation of histomorpholgy
Page 174 and 175: P-283 Homologous intrauterine insem
Page 176 and 177:
P-310 Uterine contraction after emb
Page 178 and 179:
Paramedical - laboratoryP-335 To en
Page 180 and 181:
P-363 Effects of pharmacologically
Page 182 and 183:
P-393 "It is not his child, it is o
Page 184 and 185:
P-420 Differences in somatic cell g
Page 186 and 187:
P-446 Comparison between fresh or v
Page 188 and 189:
P-475 Use of ovarian reserve parame
Page 190 and 191:
P-503 Low follicular fluid tyrosine
Page 192 and 193:
P-531 Addition of luteal estradiol
Page 194 and 195:
P-557 Altered sensitivity rather th
Page 196 and 197:
P-585 A late presentation of obstru
Page 198 and 199:
184
Page 200 and 201:
Anastácio A. 60Andersen A.N. 80And
Page 202 and 203:
Bowman N. 55, 153Boyer P. 147Bozdag
Page 204 and 205:
Critchley H.O.D. 167Crivello A.M. 1
Page 206 and 207:
Farrag A. 143Farreras A. 149, 150Fa
Page 208 and 209:
Guarneri C. 143Gudi A. 57Guérif F.
Page 210 and 211:
Izzi-Engbeaya C. 177Izzo C.R. 148JJ
Page 212 and 213:
Kuchenbecker W.K.H. 182Kuchiki M. 1
Page 214 and 215:
Makedos A. 179Makyan Z. 134Malcov M
Page 216 and 217:
Nascimento A.M. 58, 73, 143,160, 17
Page 218 and 219:
Piccinini C.A. 166Piccolomini M. 17
Page 220 and 221:
Sanad A. 182Sanchez A.M. 158Sánche
Page 222 and 223:
Surlan L. 152, 164Sutcliffe A.G. 10
Page 224 and 225:
Velthut-Meikas A. 170Veltman D.J. 5
Page 226 and 227:
Zervomanolakis I. 87Zeyneloglu H.B.
Page 228:
Achevé d’imprimer par :
show all

Final programme - eshre 2013

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?